Home > Insider Trading > Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc. (HALO)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
41 - 50
Next >>

Hedge Funds Are Getting Bullish On Halozyme Therapeutics, Inc. (HALO)

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...

Keep Reading →

September 28th, 2020 - Hedge Funds News

Did Hedge Funds Make The Right Call On Halozyme Therapeutics, Inc. (HALO) ?

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Keep Reading →

July 17th, 2020 - Hedge Funds News

Here is What Hedge Funds Think About Halozyme Therapeutics, Inc. (HALO)

In this article you are going to find out whether hedge funds think Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a good investment right now.

Keep Reading →

June 16th, 2020 - Hedge Funds News

Is Halozyme Therapeutics (HALO) a Smart Long-term Buy?

First Eagle Investment Management recently released its Q1 2020 Investor Letter, a copy of which you can download below.

Keep Reading →

May 29th, 2020 - Hedge Fund Investor Letters News

Halozyme Therapeutics (HALO) Stock Is Absurdly Cheap Right Now

Artisan Mid Cap Fund recently released its Q1 2020 Investor Letter, a copy of which you can download below.

Keep Reading →

May 11th, 2020 - Hedge Fund Investor Letters News

Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock?

We hate to say this but, we told you so.

Keep Reading →

March 29th, 2020 - Hedge Funds News

Hedge Fund and Insider Trading News: Paul Tudor Jones, Ken Griffin, Anthony Scaramucci, Massar Capital, Prosperity Bancshares, Inc. (PB), MoreHalozyme Therapeutics, Inc. (HALO), and More

BOSTON (Reuters) - Citadel, the Chicago-based hedge fund giant led by billionaire Ken Griffin, has so far weathered the coronavirus market storm well, turning a slight profit in its flagship Wellington...

Keep Reading →

March 24th, 2020 - Hedge Funds Insider Trading

Hedge Funds Are Betting On Halozyme Therapeutics, Inc. (HALO)

"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.

Keep Reading →

December 6th, 2019 - Hedge Funds News

is Halozyme Therapeutics, Inc. (HALO) Going To Burn These Hedge Funds?

Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock.

Keep Reading →

October 23rd, 2019 - Hedge Funds News

Is Halozyme Therapeutics, Inc. (HALO) A Good Stock To Buy?

It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and average hedge fund losing...

Keep Reading →

June 11th, 2019 - Hedge Funds News